QID 353969

Date Published: 2022-07-05

QID 353969: Amazon Linux Security Advisory for log4j-cve-2021-44228-hotpatch : ALAS2-2022-1806

Versions of the apache log4j hotpatch package before log4j-cve-2021-44228-hotpatch-1.3-5 are affected by a race condition that could lead to a local privilege escalation. the apache log4j hotpatch is not a replacement for updating to a log4j version that mitigates( CVE-2021-44228 or( CVE-2021-45046, it provides a temporary mitigation to( CVE-2021-44228 by hotpatching local java virtual machines.
To do so, the hotpatch script iterates through all running java processes, performs several checks, and executes the java virtual machine with the same permissions and capabilities as the running process to load the hotpatch.
Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

CVSS V3 rated as Critical - 8.6 severity.

CVSS V2 rated as Medium - 5.4 severity.

Solution

Please refer to Amazon advisory: ALAS2-2022-1806 for affected packages and patching details, or update with your package manager.

Vendor References

ALAS2-2022-1806 - alas.aws.amazon.com/AL2/ALAS-2022-1806.html

CVEs related to QID 353969

Software Advisories

Advisory ID	Software	Component	Link
ALAS2-2022-1806	Amazon Linux 2		alas.aws.amazon.com/AL2/ALAS-2022-1806.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].